Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Abbott India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500488 | NSE: ABBOTINDIA

Watchlist

NSE BSE

28655.35

20-Dec-2024

Open
High
Low
Previous Close

28927.00
29218.60
28501.00
29053.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

14576
4206.13
30521.00
22239.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

60,853.11
47.37
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

59,747.41
1.43%
17.28

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.83
7.40
5.98

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.66
13.95
6.08

PAT CAGR (%)

10 Years
5 Years
3 Years

18.03
15.17
14.57

P:E (Median)

8 Years
5 Years
3 Years

48.06
50.20
48.96

P:BV (Average)

8 Years
5 Years
3 Years

14.94
14.94
15.28

EV:EBITDA (Average)

8 Years
5 Years
3 Years

29.11
33.50
32.64

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 565.28 643.16 734.32 852.32
P/E Ratio 48.64 42.75 37.44 32.26
Revenue 5849 6402 7039 7833
EBITDA 1453 1642 1868 2527
Net Income 1201 1366 1560 1811
ROA 24.6 24.5 24.1 22.2
P/Bk Ratio 15.8 13.32 11.06 9.59
ROE 34.88 33.61 32.71 51.73
FCFF 1307.91 1111.41 1274.77 1389.16
FCFF Yield 2.32 1.97 2.26 2.46

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,632.67 1,494.14 9.27% 1,557.61 1,479.00 5.32% 1,438.63 1,343.08 7.11% 1,437.14 1,322.19 8.69%
Expenses 1,193.71 1,113.26 7.23% 1,166.60 1,124.00 3.79% 1,109.10 1,062.96 4.34% 1,049.45 1,009.99 3.91%
EBITDA 438.96 380.88 15.25% 391.01 355.00 10.14% 329.53 280.12 17.64% 387.69 312.20 24.18%
EBIDTM 26.89% 25.49% 25.10% 24.00% 22.91% 20.86% 26.98% 23.61%
Other Income 60.48 55.51 8.95% 67.33 56.00 20.23% 81.15 49.64 63.48% 55.61 44.23 25.73%
Interest 2.50 3.13 -20.13% 2.75 3.34 -17.66% 2.81 4.01 -29.93% 3.17 3.79 -16.36%
Depreciation 17.51 17.84 -1.85% 18.37 17.17 6.99% 18.19 17.34 4.90% 17.97 17.81 0.90%
PBT 479.43 415.42 15.41% 437.22 390.49 11.97% 389.68 308.41 26.35% 422.16 334.83 26.08%
Tax 120.82 102.48 17.90% 109.21 100.25 8.94% 102.62 76.99 33.29% 111.18 88.00 26.34%
PAT 358.61 312.94 14.59% 328.01 290.24 13.01% 287.06 231.42 24.04% 310.98 246.83 25.99%
PATM 21.96% 20.94% 21.06% 19.62% 19.95% 17.23% 21.64% 18.67%
EPS 169.16 147.61 14.60% 154.72 136.91 13.01% 135.41 109.16 24.05% 146.69 116.43 25.99%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 6,066.05 5,848.91 5,348.73 4,913.32 4,310.02 4,093.14 3,678.60 3,298.50 2,902.56 2,614.50 2,289.33 Net Sales Growth 7.58% 9.35% 8.86% 14.00% 5.30% 11.27% 11.52% 13.64% 11.02% 14.20% Cost Of Goods Sold 3,330.81 3,220.61 2,975.06 2,657.21 2,390.92 2,315.63 2,088.60 1,900.43 1,714.96 1,494.45 1,314.45 Gross Profit 2,735.24 2,628.30 2,373.67 2,256.11 1,919.10 1,777.51 1,590.01 1,398.07 1,187.60 1,120.05 974.87 GP Margin 45.09% 44.94% 44.38% 45.92% 44.53% 43.43% 43.22% 42.39% 40.92% 42.84% 42.58% Total Expenditure 4,518.86 4,395.86 4,143.24 3,831.74 3,391.13 3,336.96 3,074.56 2,775.10 2,507.75 2,250.77 1,978.01 Power & Fuel Cost - 16.63 17.15 14.98 12.74 13.73 12.61 10.26 7.74 6.98 5.96 % Of Sales - 0.28% 0.32% 0.30% 0.30% 0.34% 0.34% 0.31% 0.27% 0.27% 0.26% Employee Cost - 576.58 563.59 579.46 492.65 476.11 435.58 393.69 345.27 341.09 305.40 % Of Sales - 9.86% 10.54% 11.79% 11.43% 11.63% 11.84% 11.94% 11.90% 13.05% 13.34% Manufacturing Exp. - 86.07 40.71 20.63 16.51 18.33 14.42 11.52 13.14 11.94 11.59 % Of Sales - 1.47% 0.76% 0.42% 0.38% 0.45% 0.39% 0.35% 0.45% 0.46% 0.51% General & Admin Exp. - 233.47 258.70 229.35 200.23 209.71 267.14 239.06 205.33 191.08 152.91 % Of Sales - 3.99% 4.84% 4.67% 4.65% 5.12% 7.26% 7.25% 7.07% 7.31% 6.68% Selling & Distn. Exp. - 210.47 217.97 249.77 199.90 222.07 191.15 156.94 148.33 152.27 135.60 % Of Sales - 3.60% 4.08% 5.08% 4.64% 5.43% 5.20% 4.76% 5.11% 5.82% 5.92% Miscellaneous Exp. - 52.03 70.06 80.34 78.18 81.38 65.05 63.19 72.98 52.96 135.60 % Of Sales - 0.89% 1.31% 1.64% 1.81% 1.99% 1.77% 1.92% 2.51% 2.03% 2.28% EBITDA 1,547.19 1,453.05 1,205.49 1,081.58 918.89 756.18 604.04 523.40 394.81 363.73 311.32 EBITDA Margin 25.51% 24.84% 22.54% 22.01% 21.32% 18.47% 16.42% 15.87% 13.60% 13.91% 13.60% Other Income 264.57 248.32 154.29 83.35 83.47 114.66 113.98 118.09 60.15 51.24 48.48 Interest 11.23 12.45 15.99 19.10 18.28 8.53 2.25 3.82 2.04 2.52 0.50 Depreciation 72.04 71.17 69.97 66.10 58.13 59.61 16.92 16.19 16.43 14.44 14.94 PBT 1,728.49 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85 621.48 436.49 398.01 344.36 Tax 443.83 416.53 324.41 281.03 235.26 209.77 248.52 220.26 159.84 142.76 115.40 Tax Rate 25.68% 25.75% 25.47% 26.03% 25.41% 26.13% 35.56% 35.44% 36.62% 35.87% 33.51% PAT 1,284.66 1,201.22 949.41 798.70 690.69 592.93 450.33 401.22 276.65 255.25 228.96 PAT before Minority Interest 1,284.66 1,201.22 949.41 798.70 690.69 592.93 450.33 401.22 276.65 255.25 228.96 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.18% 20.54% 17.75% 16.26% 16.03% 14.49% 12.24% 12.16% 9.53% 9.76% 10.00% PAT Growth 18.79% 26.52% 18.87% 15.64% 16.49% 31.67% 12.24% 45.03% 8.38% 11.48% EPS 605.97 566.61 447.83 376.75 325.80 279.68 212.42 189.25 130.50 120.40 108.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,698.89 3,188.54 2,819.79 2,602.16 2,431.70 2,008.59 1,692.76 1,386.94 1,195.60 937.53 Share Capital 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 Total Reserves 3,637.48 3,124.77 2,754.38 2,536.64 2,374.69 1,959.59 1,650.56 1,352.37 1,174.35 916.28 Non-Current Liabilities 136.03 144.02 184.18 189.62 209.60 62.36 40.75 34.84 29.25 432.46 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 115.12 93.46 92.40 89.75 84.84 75.43 55.35 47.22 38.64 438.98 Current Liabilities 1,342.72 1,206.02 1,203.19 1,030.86 891.11 856.89 668.08 631.64 382.27 834.22 Trade Payables 1,002.69 891.99 889.45 762.67 657.77 663.52 480.62 474.69 230.14 193.56 Other Current Liabilities 191.79 177.30 174.02 136.76 118.25 89.42 81.80 77.90 86.90 59.35 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 148.24 136.73 139.72 131.43 115.09 103.96 105.66 79.05 65.23 581.31 Total Liabilities 5,177.64 4,538.58 4,207.16 3,822.64 3,532.41 2,927.84 2,401.59 2,053.42 1,607.12 2,204.21 Net Block 224.94 236.91 271.00 250.78 269.83 104.96 81.38 109.60 108.46 96.04 Gross Block 424.50 366.93 425.90 340.62 344.84 164.52 124.25 139.69 122.83 215.65 Accumulated Depreciation 199.56 130.02 154.90 89.84 75.01 59.56 42.87 30.10 14.37 119.61 Non Current Assets 1,931.80 1,513.47 354.12 335.23 327.76 166.85 136.12 160.41 156.49 540.81 Capital Work in Progress 10.11 3.66 0.66 0.66 1.64 0.73 2.17 6.28 2.83 3.91 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 80.18 97.88 79.35 78.80 50.91 56.69 48.91 41.53 42.47 438.62 Other Non Current Assets 1,616.57 1,175.02 3.11 4.99 5.38 4.47 3.66 3.00 2.73 2.24 Current Assets 3,245.84 3,025.11 3,853.04 3,487.41 3,204.65 2,760.98 2,265.47 1,893.02 1,450.63 1,663.39 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 619.58 648.85 687.82 717.59 527.17 606.79 585.33 500.63 370.10 384.13 Sundry Debtors 319.11 318.80 288.16 250.21 317.91 276.11 263.44 176.22 145.02 129.15 Cash & Bank 2,134.49 1,937.06 2,749.22 2,409.04 2,197.38 1,684.28 1,031.35 1,090.92 839.42 643.89 Other Current Assets 172.66 70.06 73.19 67.79 162.19 193.80 385.35 125.24 96.08 506.22 Short Term Loans & Adv. 85.54 50.34 54.65 42.78 105.79 93.24 289.55 106.23 79.51 488.68 Net Current Assets 1,903.12 1,819.09 2,649.85 2,456.55 2,313.54 1,904.09 1,597.39 1,261.38 1,068.36 829.17 Total Assets 5,177.64 4,538.58 4,207.16 3,822.64 3,532.41 2,927.83 2,401.59 2,053.43 1,607.12 2,204.20

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,212.81 893.39 947.66 726.74 626.13 499.13 152.70 307.22 248.68 214.78 PBT 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85 621.48 436.49 398.01 344.36 Adjustment -129.85 -62.70 23.30 24.99 -17.22 -77.46 -76.92 -37.02 -23.98 -37.19 Changes in Working Capital 129.38 23.13 133.62 11.26 69.82 134.41 -186.96 66.52 21.85 23.48 Cash after chg. in Working capital 1,617.28 1,234.25 1,236.65 962.20 855.30 755.80 357.61 466.00 395.87 330.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -404.47 -340.86 -288.99 -235.46 -229.17 -256.67 -204.90 -158.78 -147.20 -115.87 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -416.03 -147.71 -395.84 -71.82 -401.21 -257.00 -214.84 -155.41 -77.19 -186.72 Net Fixed Assets -64.02 55.97 -85.28 5.20 -181.23 -38.83 19.55 -20.31 93.90 -9.06 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -352.01 -203.68 -310.56 -77.02 -219.98 -218.17 -234.39 -135.10 -171.09 -177.66 Cash from Financing Activity -744.71 -638.72 -637.38 -581.79 -216.79 -142.80 -102.43 -89.76 -80.29 -57.58 Net Cash Inflow / Outflow 52.07 106.96 -85.56 73.13 8.13 99.33 -164.56 62.05 91.19 -29.52 Opening Cash & Equivalents 239.67 132.71 218.27 145.14 137.01 37.68 202.24 140.19 49.00 78.52 Closing Cash & Equivalent 291.74 239.67 132.71 218.27 145.14 137.01 37.68 202.24 140.19 49.00

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 1721.76 1480.48 1306.18 1203.71 1127.50 932.19 786.76 646.43 562.65 441.20 ROA 24.73% 21.71% 19.89% 18.78% 18.36% 16.90% 18.01% 15.12% 13.39% 11.20% ROE 35.31% 32.07% 29.95% 27.89% 27.09% 24.66% 26.35% 21.54% 23.93% 26.54% ROCE 47.34% 42.93% 40.53% 37.52% 36.54% 37.88% 40.61% 33.96% 37.55% 39.98% Fixed Asset Turnover 15.27 13.85 13.12 13.04 16.07 25.48 25.06 22.39 15.63 10.91 Receivable days 19.26 20.18 19.54 23.19 26.49 26.77 24.26 19.95 18.91 18.77 Inventory Days 38.30 44.44 51.02 50.82 50.56 59.14 59.93 54.07 52.03 58.54 Payable days 107.36 109.28 113.47 108.42 78.62 76.56 66.93 54.71 38.57 32.92 Cash Conversion Cycle -49.80 -44.66 -42.91 -34.41 -1.57 9.35 17.26 19.31 32.37 44.39 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 130.94 80.66 57.53 51.65 95.10 311.82 163.60 215.33 158.63 685.07

Top Investors:

sbi arbitrage opportunities fund

canara robeco mutual fund a/c

investor education and protection fund (iepf)

Annual Reports:

News Update:

Abbott India launches Pneumococcal Conjugate Vaccine ‘PneumoShield 14’
28th Nov 2024, 16:30 PM

A strain refers to a genetic or structural variant or subtype of a microorganism
Read More
Abbott India signs patent license agreement with Takeda Pharmaceuticals
20th Sep 2024, 09:21 AM

Vonoprazan, a first-of-its kind therapy, will help make it easier for patients to comply with their treatment and manage their condition better
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback